Home › NDC Lookup › RxCUI directory › RxCUI 1369728

Pomalidomide 2 MG Oral Capsule [Pomalyst] — RxCUI 1369728

Name: Pomalidomide 2 MG Oral Capsule [Pomalyst] (RxCUI 1369728)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1369728 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1369728

Official namePomalidomide 2 MG Oral Capsule [Pomalyst]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asPomalyst 2 MG Oral Capsule

FDA products mapped4

Package NDCs mapped8

Reported Medicaid activity (SDUD)2,329 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pomalidomide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Pomalidomide is closely related to thalidomide — a drug that caused devastating birth defects in thousands of children decades ago. Because of that history, the FDA requires a spec...
Why do I need to go through such a strict process just to get this medication?
You can take it with or without food — it's flexible that way. That said, a very large, high-fat meal can slow down how quickly it's absorbed and slightly reduce how much reaches y...
Can I take this capsule with food, or does it need to be on an empty stomach?

📖 Read our full Pomalidomide guide →

🕸️ Concept Web — How Pomalidomide 2 MG Oral Capsule [Pomalyst] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Pomalidomide 2 MG Oral Capsule [Pomalyst] RxCUI 1369728 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Pomalidomide 1369713 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Pomalyst 1369719 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Pomalidomide Oral Capsule 1369717 SCDF
- Pomalidomide Oral Product 1369715 SCDG
- Pomalidomide Pill 1369716 SCDG
- Pomalidomide Oral Capsule [Pomalyst] 1369721 SBDF
- Pomalyst Oral Product 1369722 SBDG
- Pomalyst Pill 1369723 SBDG
- Oral Capsule 316965 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Pomalidomide 2 MG Oral Capsule 1369726 SCD
- Pomalidomide 2 MG 1369725 SCDC
- Pomalidomide 2 MG [Pomalyst] 1369727 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Pomalidomide 2 MG Oral Capsule SCD · 1369726
Pomalidomide 2 MG SCDC · 1369725
Pomalidomide Oral Capsule SCDF · 1369717
Pomalidomide Oral Product SCDG · 1369715
Pomalidomide Pill SCDG · 1369716

Brand-Name Concepts

Pomalidomide 2 MG [Pomalyst] SBDC · 1369727
Pomalidomide Oral Capsule [Pomalyst] SBDF · 1369721
Pomalyst Oral Product SBDG · 1369722
Pomalyst Pill SBDG · 1369723
Pomalyst BN · 1369719

📦 FDA Products & Package NDCs

4 products · 8 package NDCs

8 package NDCs map to RxCUI 1369728 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
59572-0501-00	100 CAPSULE in 1 BOTTLE (59572-501-00)	Pomalyst	Celgene Corporation	2013-02-18
59572-0501-21	21 CAPSULE in 1 BOTTLE (59572-501-21)	Pomalyst	Celgene Corporation	2013-02-18
59572-0502-00	100 CAPSULE in 1 BOTTLE (59572-502-00)	Pomalyst	Celgene Corporation	2013-02-18
59572-0502-21	21 CAPSULE in 1 BOTTLE (59572-502-21)	Pomalyst	Celgene Corporation	2013-02-18
59572-0503-00	100 CAPSULE in 1 BOTTLE (59572-503-00)	Pomalyst	Celgene Corporation	2013-02-18
59572-0503-21	21 CAPSULE in 1 BOTTLE (59572-503-21)	Pomalyst	Celgene Corporation	2013-02-18
59572-0504-00	100 CAPSULE in 1 BOTTLE (59572-504-00)	Pomalyst	Celgene Corporation	2013-02-18
59572-0504-21	21 CAPSULE in 1 BOTTLE (59572-504-21)	Pomalyst	Celgene Corporation	2013-02-18

Observed labelers: Celgene Corporation (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.